Combined effects of curcumin and lycopene or bixin in yoghurt on inhibition of LDL oxidation and increases in HDL and paraoxonase levels in streptozotocin-diabetic rats

International Journal of Molecular Sciences

Volumn 18, Issue 4, 2017, Pages

  Assis, Renata Pires ^a   Arcaro, Carlos Alberto ^a   Gutierres, Vânia Ortega ^a   Oliveira, Juliana Oriel ^a   Costa, Paulo Inácio ^a   Baviera, Amanda Martins ^a   Brunetti, Iguatemy Lourenço ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Bixin; Cardiovascular risk; Curcumin; Diabetes mellitus; Lycopene; Oxidative stress

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; BIXIN; CARBONYL DERIVATIVE; CAROTENOID; CASPASE; CHOLESTEROL; CURCUMIN; GLUCOSE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LYCOPENE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; YOGHURT; ARYLDIALKYLPHOSPHATASE;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTENSOR DIGITORUM LONGUS MUSCLE; FLUID INTAKE; FOOD INTAKE; INSULIN DEPENDENT DIABETES MELLITUS; LIPID OXIDATION; MALE; MUSCLE MASS; NONHUMAN; RAT; RETROPERITONEAL FAT; SOLEUS MUSCLE; URINE VOLUME; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENT; DRUG POTENTIATION; OXIDATIVE STRESS; WISTAR RAT;

ANIMALS; ARYLDIALKYLPHOSPHATASE; CAROTENOIDS; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; DRUG SYNERGISM; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; YOGURT;

EID: 85016097819     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18040332     Document Type: Article

References (71)

1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2009, 32, S62-S67.
2. Fowler, M.J. Microvascular and Macrovascular Complications of Diabetes. Clin. Diabetes 2008, 26, 77-82.
3. International Diabetes Federation. IDF Diabetes Atlas, 7th ed. Available online: http://www.diabetesatlas.org/ (accessed on 12 December 2016).
4. Hu, F.B. Globalization of diabetes: The role of diet, lifestyle, and genes. Diabetes Care 2011, 34, 1249-1257.
5. Da Rocha Fernandes, J.; Ogurtsova, K.; Linnenkamp, U.; Guariguata, L.; Seuring, T.; Zhang, P.; Cavan, D.; Makaroff, L.E. IDF Diabetes Atlas estimates of 2014 global health expenditure on diabetes. Diabetes Res. Clin. Pract. 2016, 117, 48-54.
6. Kalofoutis, C.; Piperi, C.; Kalofoutis, A.; Harris, F.; Phoenix, D.; Singh, J. Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches. Exp. Clin. Cardiol. 2010, 12, 17-28.
7. Laakso, M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms. Diabetes Care 2010, 33, 442-449.
8. Odegaard, A.O.; Jacobs, D.R., Jr.; Sanchez, O.A.; Goff, D.C., Jr.; Reiner, A.P. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc. Diabetol. 2016, 2016, 1-12.
9. Sivitz, W.I.; Yorek, M.A. Mitochondrial dysfunction in diabetes: From molecular mechanisms to functional significance and therapeutic opportunities. Antioxid. Redox Signal. 2010, 12, 537-577.
10. Levitan, I.; Volkov, S.; Subbaiah, P.V. Oxidized LDL: Diversity, patterns of recognition, and pathophysiology. Antioxid. Redox Signal. 2010, 13, 39-75.
11. Aviram, M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993, 98, 1-9.
12. Steinberg, D.; Witztum, J.L. Oxidized low-density lipoprotein and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 2311-2316.
13. Brown, M.S.; Goldstein, J.L. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 1983, 52, 223-261.
14. Galle, J.; Hansen-Hagge, T.; Wanner, C.; Seibold, S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 2006, 185, 219-226.
15. Fuhrman, B.; Volkova, N.; Rosenblat, M.; Aviram, M. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid. Redox Signal. 2000, 2, 491-506.
16. Prabhakar, P.K.; Kumar, A.; Doblec, M. Combination therapy: A new strategy to manage diabetes and its complications. Phytomedicine. 2014, 21, 123-130.
17. Zhang, Y.J.; Gan, R.W.; Li, S.; Zhou, Y.; Li, A.; Xu, D.; Li, H. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules. 2015, 20, 21138-21156.
18. Liu, R.H. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am. J. Clin. Nutr. 2003, 78, 517-520.
19. Gutierres, V.O.; Pinheiro, C.M.; Assis, R.P.; Vendramini, R.C.; Pepato, M.T.; Brunetti, I.L. Curcumin-supplemented yoghurt improves physiological and biochemical markers of experimental diabetes. Br. J. Nutr. 2012, 108, 440-448.
20. Arcaro, C.A.; Gutierres, V.O.; Assis, R.P.; Moreira, T.F.; Costa, P.I.; Baviera, A.M.; Brunetti, I.L. Piperine, a natural bioenhancer, nullifies the antidiabetic and antioxidant activities of curcumin in streptozotocin-diabetic rats. PLoS ONE. 2014, 9, 1-21.
21. Roehrs, M.; Figueiredo, C.G.; Zanchi, M.M.; Bochi, G.V.; Moresco, R.N.; Quatrin, A.; Somacal, A.; Conte, L.; Emanuelli, T. Bixin and norbixin have opposite effects on glycemia, lipidemia, and oxidative stress in streptozotocin-induced diabetic rats. Int. J. Endocrinol. 2014, 2014, 1-10.
22. Zhu, J.; Wang, C.G.; Xu, Y.G. Lycopene attenuates endothelial dysfunction in streptozotocin-induced diabetic rats by reducing oxidative stress. Pharm. Biol. 2011, 49, 1144-1149.
23. Ozmen, O.; Topsakal, S.; Haligur, M.; Aydogan, A.; Dincoglu, D. Effects of caffeine and lycopene in experimentally induced diabetes mellitus. Pancreas 2016, 45, 579-583.
24. Gahruie, H.H.; Eskandari, M.H.; Mesbahi, G.; Hanifpour, M.A. Scientific and technical aspects of yogurt fortification: A review. Food Sci. Hum. Well. 2015, 4, 1-8.
25. Langella, C.; Naviglio, D.; Marino, M.; Gallo, M. Study of the effects of a diet supplemented with active components on lipid and glycemic profiles. Nutrition. 2015, 31, 180-186.
26. Erejuwa, O.O.; Sulaiman, S.A.; Ab Wahab, M.S. Modulation of gut microbiota in the management of metabolic disorders: The prospects and challenges. Int. J. Mol. Sci. 2014, 15, 4158-4188.
27. Boulangé, C.L.; Neves, A.L.; Chilloux, J.; Nicholson, J.K.; Dumas, M.E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome. Med. 2015, 8, 42.
28. Kobyliak, N.; Conte, C.; Cammarota, G.; Haley, A.P.; Styriak, I.; Gaspar, L.; Fusek, J.; Rodrigo, L.; Kruzliak, P. Probiotics in prevention and treatment of obesity: A critical view. Nutr. Metab. 2016.
29. Yoo, J.Y.; Kim, S.S. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients 2016, 8, 173.
30. Palozza, P.; Catalano, A.; Simone, R.E.; Mele, M.C.; Cittadini, A. Effect of lycopene and tomato products on cholesterol metabolism. Ann. Nutr. Metab. 2012, 61, 126-134.
31. Etoh, H.; Utsunomiya, Y.; Komori, A.; Murakami, Y.; Oshima, S.; Inakuma, T. Carotenoids in human blood plasma after ingesting paprika juice. Biosci. Biotechnol. Biochem. 2000, 64, 1096-1098.
32. Best, L.; Elliott, A.C.; Brown, P.D. Curcumin induces electrical activity in rat pancreatic beta-cells by activating the volume-regulated anion channel. Biochem. Pharmacol. 2007, 73, 1768-1775.
33. Junod, A.; Lambert, A.E.; Stauffacher, W.; Renold, A.E. Diabetogenic action of streptozotocin: Relationship of dose to metabolic response. J. Clin. Investig. 1969, 48, 2129-2139.
34. Gutierres, V.O.; Campos, M.L.; Arcaro, C.A.; Assis, R.P.; Baldan-Cimatti, H.M.; Peccinini, R.G.; Paula-Gomes, S.; Kettelhut, I.C.; Baviera, A.M.; Brunetti, I.L. Curcumin Pharmacokinetic and Pharmacodynamic Evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s). Evid. Based. Complement. Altern. Med. 2015, 2015, 1-13.
35. Ak, T.; Gülçin, I. Antioxidant and radical scavenging properties of curcumin. Chem. Biol. Interact. 2008, 174, 27-37.
36. Barzegar, A.; Moosavi-Movahedi, A.A. Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PLoS ONE. 2011, 6, 1-7.
37. Meghana, K.; Sanjeev, G.; Ramesh, B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: A prophylactic and protective role. Eur. J. Pharmacol. 2007, 577, 183-191.
38. Parker, R.S. Absorption, metabolism, and transport of carotenoids. FASEB J. 1996, 10, 542-551.
39. Park, J.S.; Mathison, N.D.; Chew, B.P. Uptake and immunomodulatory role of bixin in dogs. J. Anim. Sci. 2016, 94, 135-143.
40. Kim, H.G.; Lee, J.H.; Lee, S.J.; Oh, J.H.; Shin, E.; Jang, Y.P.; Lee, Y.J. The increased cellular uptake and biliary excretion of curcumin by quercetin: A possible role of albumin binding interaction. Drug Metab. Dispos. 2012, 40, 1452-1455.
41. Yang, M.; Wu, Y.; Li, J.; Zhou, H.; Wang, X. Binding of curcumin with bovine serum albumin in the presence of ι-carrageenan and implications on the stability and antioxidant activity of curcumin. J. Agric. Food Chem. 2013, 61, 7150-7155.
42. Mahfouz, M.M.; Zhou, S.Q.; Kummerow, F.A. Curcumin prevents the oxidation and lipid modification of LDL and its inhibition of prostacyclin generation by endothelial cells in culture. Prostaglandins Other Lipid Mediat. 2009, 90, 13-20.
43. Di Mascio, P.; Kaiser, S.; Sies, H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys. 1989, 274, 532-538.
44. Miller, N.J.; Sampson, J.; Candeias, L.P.; Bramley, P.M.; Rice-Evans, C.A. Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996, 384, 240-242.
45. Litvinov, D.; Mahini, H.; Garelnabi, M. Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in arteriosclerosis diseases. N. Am. J. Med. Sci. 2012, 4, 523-532.
46. Gugliucci, A.; Menini, T. Paraoxonase 1 and HDL maturation. Clin. Chim. Acta 2015, 439, 5-13.
47. Aviram, M.; Rosenblat, M.; Bisgaier, C.L.; Newton, R.S.; Primo-Parmo, S.L.; La Du, B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Investig. 1998, 101, 1581-1590.
48. Mackness, M.; Mackness, B. Targeting paraoxonase-1 in atherosclerosis. Expert Opin. Ther. Targets 2013, 17, 829-837.
49. Mackness, B.; Durrington, P.N.; Abuashia, B.; Boulton, A.J.; Mackness, M.I. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin. Sci. 2000, 98, 355-363.
50. Pereira, R.R.; de Abreu, I.C.M.E.; Guerra, J.F.C.; Lage, N.N.; Lopes, J.M.M.; Silva, M.; Lima, W.G.; Silva, M.E.; Pedrosa, M.L. Açai (Euterpe oleracea Mart.) Upregulates Paraoxonase 1 Gene Expression and Activity with Concomitant Reduction of Hepatic Steatosis in High-Fat Diet-Fed Rats. Oxid. Med. Cell. Longev. 2016, 2016, 1-13.
51. Ferretti, G.; Bacchetti, T.; Marchionni, C.; Caldarelli, L.; Curatola, G. Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity. Acta Diabetol. 2001, 38, 163-169.
52. Mastorikou, M.; Mackness, B.; Liu, Y.; Mackness, M. Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides. Diabet. Med. 2008, 25, 1049-1055.
53. Varatharajalu, R.; Garige, M.; Leckey, L.C.; Reyes-Gordillo, K.; Shah, R.; Lakshman, M.R. Protective Role of Dietary Curcumin in the Prevention of the Oxidative Stress Induced by Chronic Alcohol with respect to Hepatic Injury and Antiatherogenic Markers. Oxid. Med. Cell. Longev. 2016, 2016, 1-10.
54. Lou-Bonafonte, J.M.; Gabás-Rivera, C.; Navarro, J.; Osada, M.A. PON1 and Mediterranean Diet. Nutrients 2015, 7, 4068-4092.
55. McEneny, J.; Wade, L.; Young, I.S.; Masson, L.; Duthie, G.; McGinty, A.; McMaster, C.; Thies, F. Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals. J. Nutr. Biochem. 2013, 24, 163-168.
56. Pepato, M.T.; Keller, E.H.; Baviera, A.M.; Kettelhut, I.C.; Vendramini, R.C.; Brunetti, I.L. Anti-diabetic activity of Bauhinia forficata decoction in streptozotocin-diabetic rats. J. Ethnopharmacol. 2002, 81, 191-197.
57. Trinder, P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J. Clin. Pathol. 1969, 22, 158-161.
58. Pilz, J.; Meineke, I.; Gleiter, C. Measurement of free and bound malondialdehyde in plasma by high performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J. Chromatogr. B. Biomed. Sci. Appl. 2000, 742, 315-325.
59. Kohn, H.I.; Liversedge, M. On a new aerobic metabolite whose production by brain is inhibited by apomorphine, emetine, ergotamine, epinephrine, and menadione. J. Pharmacol. Exp. Ther. 1944, 82, 92-300.
60. Levine, R.L.; Williams, J.A.; Stadtman, E.R.; Shacter, E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1944, 233, 346-357.
61. Sedlak, J.; Lindsay, R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissues with Ellmann’s reagent. Anal. Biochem. 1968, 25, 192-205.
62. Costa, L.G.; McDonald, B.E.; Murphy, S.D.; Omenn, G.S.; Richter, R.J.; Motulsky, A.G.; Furlong, C.E. Serum Paraoxonase and its influence on paraoxon and chlorpyritos-oxontocixity in rats. Toxicol. Appl. Pharmacol. 1990, 103, 66-76.
63. Budavari, S.; O’Neil, M.J.; Smith, A.; Heckelman, P.E.; Kinneary, J.F. The Merck Index (an Encyclopedia of Chemicals, Drugs, and Biologicals), 12th ed.; Merck: Whitehouse Station, NJ, USA, 2006; p. 1208.
64. Richter, R.J.; Jarvik, G.P.; Furlong, C.E. Determination of paraoxonase 1 status without the use of toxic organophosphate substrates. Circ. Cardiovasc. Genet. 2008, 1, 147-152.
65. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
66. Beauchamp, C.; Fridovich, I. Superoxide Dismutase: Improved assays and assay applicable to acrylamide gels. Anal. Biochem. 1971, 44, 276-287.
67. Beers, R.F., Jr.; Sizer, I.W. A spectrophotometric method of measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 1952, 195, 133-140.
68. Rush, J.W.; Sandiford, S.D. Plasma glutathione peroxidase in healthy young adults: Influence of gender and physical activity. Clin. Biochem. 2003, 36, 345-351.
69. Zhang, L.; Chen, B.; Tang, L. Metabolic memory: Mechanisms and implications for diabetic retinopathy. Diabetes Res. Clin. Pract. 2012, 96, 286-293.
70. Yamagishi, S.I.; Nakamura, N.; Matsui, T. Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory. J. Diabetes 2017, 9, 141-148.
71. Erejuwa, O.O. Management of diabetes mellitus: Could simultaneous targeting of hyperglycemia and oxidative stress be a better panacea? Int. J. Mol. Sci., 2012, 13, 2965-2972.